FDA approval of GLP-1 receptor agonist (liraglutide) for use in children

被引：24
|
作者：
Bacha, Fida [1 ]
机构：
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源：
LANCET CHILD & ADOLESCENT HEALTH | 2019年 / 3卷 / 09期
关键词：
TYPE-2; METFORMIN;
D O I：
10.1016/S2352-4642(19)30236-6
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：595 / 597
页数：4
相关论文
共 50 条
  • [1] The use of GLP-1 agonist liraglutide: adhering to guidelines?
    Fatima, J.
    Pearce, S.
    DIABETIC MEDICINE, 2014, 31 : 74 - 74
  • [2] Liraglutide, GLP-1 receptor agonist, for chronic weight loss
    Moore, Katherine G.
    Shealy, Kayce
    Clements, Jennifer N.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 373 - 378
  • [3] The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
    Crane, James
    McGowan, Barbara
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (02) : 92 - 107
  • [4] The GLP-1 Receptor Agonist Liraglutide Improves Autophagy Impairment in the Diabetic Heart
    Bugyei-Twum, Antoinette
    Switzer, Jennifer
    Singh, Krishna K.
    Connelly, Kim A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [5] Characterization of the Discriminative Stimulus Effects of GLP-1 Receptor Agonist Liraglutide in Rats
    Sullivan, Leslie
    Beltran, Nina
    Serafine, Katherine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (03):
  • [6] Liraglutide: A Review of the First Once-Daily GLP-1 Receptor Agonist
    Bode, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (02): : S59 - S70
  • [7] GLP-1 agonist liraglutide improves insulin sensitivity
    Di Lellis, Maddalena Angela
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (03) : 172 - 172
  • [8] GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells
    Zhang, Xuelian
    Zhang, Liqiang
    Wang, Bo
    Zhang, Xuane
    Gu, Lei
    Guo, Kai
    Zhang, Xiaoyan
    Zhou, Zunhai
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (14) : 221 - 225
  • [9] Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide
    Camilleri, Michael
    Carlson, Paula
    Dilmaghani, Saam
    OBESITY, 2024, 32 (02) : 232 - 233
  • [10] DIFFERENT CGM EFECTTS OF GLP-1 RECEPTOR AGONIST: LIRAGLUTIDE VS. LIXISENATIDE
    Jesus, M. F.
    Garcia Seco, J. A.
    Rozas, P.
    Garcia Seco, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A98 - A98
12345